Table 4.
Expected results of the base case cost-effectiveness analysis
Cost (USD 2013) | Δ Cost | Health Utility (QALYs) | Δ Utility | ICER ($/QALY) | |
---|---|---|---|---|---|
5-Year Time Horizon | |||||
No Health Benefit | 10,712.00 | 3.71 | |||
Provider Coverage | 21,326.00 | 10,614.00 | 3.98 | 0.27 | 39,311.11 |
Male-to-Female (MTF)* | 22,545.00 | 11,833.00 | 3.98 | 0.27 | 43,825.93 |
Female-to-Male (FTM)* | 20,107.00 | 9395.00 | 3.98 | 0.27 | 34,796.30 |
10-Year Time Horizon | |||||
No Health Benefit | 23,619.00 | 6.49 | |||
Provider Coverage | 31,816.00 | 8197.00 | 7.37 | 0.88 | 9314.77 |
Male-to-Female (MTF)* | 33,034.00 | 9415.00 | 7.37 | 0.88 | 10,698.86 |
Female-to-Male (FTM)* | 30,597.00 | 6978.00 | 7.37 | 0.88 | 7929.55 |
(*) Compared to no health benefit; QALY quality-adjusted life year